Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-038423

Director acquired 1,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SEIDENBERG BETH C Director 2018-06-14 Grant or award +1,500 15,189 D
Derivatives
SEIDENBERG BETH C Director 2018-06-14 Grant or award · Non-Qualified Stock Option (Right to Buy) +5,000 5,000 D
Loading xslF345X03/doc4.xml…